The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Review

1 Aug 2018 08:41

RNS Number : 4464W
LiDCO Group Plc
01 August 2018
 

LiDCO Group Plc

("LiDCO" or the "Company")

 

Block Listing Review

 

LiDCO Group Plc (AIM: LID), the hemodynamic monitoring company, announces the following update on its block listing pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies in respect of its block listing of ordinary shares of 0.5 pence each ("Ordinary Shares").

 

Name of company

LiDCO Group Plc

Names of the schemes

LiDCO Group Plc Executive Share Option Scheme adopted on 6 June 2001 comprising Part A (Approved.), Part B (Unapproved), and Part C (Incentive Stock Options), the LiDCO Group Plc Enterprise Management Incentive Scheme 2002, the LiDCO Group Plc Unapproved Share Option Plan 2005, the LiDCO Group plc Share Option Plan 2013 formerly called the LiDCO Group Plc Enterprise Management Incentive Scheme 2013, and the LIDCO Group Plc Consultants Share Option Scheme 2003

Period of return

From 1 February 2018 to 31 July 2018

Number and class of securities not issued under the schemes

2,895,396 Ordinary Shares

Number of securities issued under the schemes during the period

Nil

Balance under the schemes of securities not yet issued at the end of the period

2,895,396 Ordinary Shares

Number and class of securities originally admitted and the date of admission

3,200,000 Ordinary Shares on 31 January 2014

 

 

For further information, please contact:

 

LiDCO Group Plc

www.lidco.com

Matthew Sassone (CEO)

Tel: +44 (0)20 7749 1500

Jill McGregor (CFO)

 

 

 

finnCap

Tel: +44 (0)20 7220 0500

Geoff Nash / Emily Watts (Corporate Finance)

 

Stephen Norcross (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or lidco@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRDFLBBVVFXBBK
Date   Source Headline
26th Jan 20064:38 pmPRNConvertible loan update
19th Jan 20067:00 amRNSProduct Development
19th Dec 20051:15 pmPRNResignation of a Director
8th Dec 20059:02 amPRNDirector Shareholding
18th Nov 20057:00 amRNSConversion of Loan
8th Nov 20057:01 amRNSPositive Study Data
3rd Nov 20057:00 amRNSUS Army Order
25th Oct 20057:01 amRNSClinical Advisory Board
18th Oct 20057:01 amRNSInterim Results
14th Oct 20051:39 pmPRNDirectorate Change
26th Sep 20059:11 amRNSNotice of Results
11th Aug 20057:02 amRNSUSD 2 Million Financing
14th Jul 20057:00 amRNSAdditional Listing
7th Jul 20057:01 amRNSNew Veterinary Application
23rd Jun 20054:00 pmRNSImpact of Review Paper
17th Jun 20057:00 amRNSBoard Appointment
16th Jun 20052:57 pmRNSAGM Statement
6th Jun 20052:38 pmPRNDirector Shareholding
1st Jun 20057:00 amRNSPositive Data
10th May 20052:20 pmPRNDirector Shareholding
9th May 20057:00 amRNSRegistration in Brazil
25th Apr 20057:00 amRNSAppointment of New Director
15th Apr 200511:46 amRNSDirector Shareholding
13th Apr 20057:00 amRNSDirector Share Options Award
7th Apr 20057:00 amRNSDirector Shareholding
30th Mar 20057:01 amRNSPreliminary Results
30th Mar 20057:01 amRNSProduct Approval in Denmark
24th Mar 20057:02 amRNSLaunch Of Software Upgrade
23rd Mar 200510:50 amPRNAdditional Listing
21st Mar 20057:02 amRNSSignificant Trial Results
15th Mar 20057:02 amRNSEuropean Approval
2nd Mar 20058:19 amRNSChange of Financial PR Agency
14th Feb 20057:00 amPRNMajor Clinical Trial
24th Jan 20053:25 pmPRNAdditional Listing
19th Jan 20054:16 pmPRNDirectorate Change
13th Jan 200511:28 amPRNAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.